Parameters | Group | n | Lnc XIST expression | P level | |
---|---|---|---|---|---|
High (n = 25) | Low (n = 25) | ||||
Age (years) |  ≤ 50 | 20 | 13 | 7 | 0.322 |
 |  > 50 | 30 | 12 | 18 |  |
Gender | Female | 27 | 7 | 20 | 0.509 |
 | Male | 23 | 18 | 5 |  |
TNM stage | T1–T2 | 23 | 15 | 8 | 0.1609 |
 | T3–T4 | 27 | 10 | 17 |  |
Serum AFP |  < 200 | 8 | 5 | 3 | 0.695 |
(ng/ml) |  > 200 | 42 | 20 | 22 |  |
Clinical stage | I–II | 25 | 16 | 9 | 0.002** |
 | III–IV | 25 | 9 | 16 |  |
Vascular invasion | Yes | 22 | 15 | 7 | 0.022* |
 | No | 28 | 10 | 18 |  |
Differentiation | Well | 5 | 3 | 2 | 0.5112 |
 | Moderate | 34 | 17 | 17 |  |
 | Poor | 11 | 5 | 6 |  |